Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The Medicines Company
Pharma
Novartis, NHS England team up in 'world-first' access agreement
As JPM kicks into gear, Novartis CEO Vas Narasimhan and British health officials unveiled a new access agreement on inclisiran.
Eric Sagonowsky
Jan 13, 2020 1:00pm
Novartis admits it overpaid for MedCo—and tots up the proof
Dec 10, 2019 12:27pm
Novartis flexes CV marketing muscles against PCSK9 rivals
Nov 25, 2019 12:37pm
Amarin for $20B? Buyout rumors run rampant after MedCo deal
Nov 25, 2019 8:39am
Medicines Co.'s PCSK9 challenger has reassuring data
Sep 2, 2019 2:30am
Achaogen wins FDA approval for new antibiotic Zemdri
Jun 26, 2018 11:55am
